About Royal care Super Speciality Hospitals Unlisted Shares
Royal Care Super Specialty Hospital started functioning as a 50-bed multi-speciality hospital from the 1st of May 2015 in the heart of Coimbatore city. Within the first year of operations, the services of our hospital were recognized by our patients and very soon came to be the preferred hospital to many in western Tamil Nadu for emergency, primary, and specialty care in virtually all the branches of modern medicine.
This necessitated an eminent expansion and created the need for a larger and more comprehensive tertiary care unit encompassing all the fields of medicine.
A 750-bed ultramodern facility was conceived at Neelambur, Coimbatore. Built within a record time of 400...
Overview
Royal Care Super Specialty Hospital started functioning as a 50-bed multi-speciality hospital from the 1st of May 2015 in the heart of Coimbatore city. Within the first year of operations, the services of our hospital were recognized by our patients and very soon came to be the preferred hospital to many in western Tamil Nadu for emergency, primary, and specialty care in virtually all the branches of modern medicine.
This necessitated an eminent expansion and created the need for a larger and more comprehensive tertiary care unit encompassing all the fields of medicine.
A 750-bed ultramodern facility was conceived at Neelambur, Coimbatore. Built within a record time of 400 days, the first phase, comprising 300 beds, was dedicated to the society in November 2016. With over 3,00,000 square feet of modern infrastructure, the center contained all necessary facilities to deliver comprehensive care under one roof.
With a commitment to make available all facilities on par with the latest advances in the Western World, Royal Care Super Speciality Hospital became the first in the country to introduce Bronchial Thermoplasty for the treatment of severe asthma. Royal Care is also the first hospital in the country to introduce the microplasma advanced oxidation for dialysis feed water disinfection to eliminate endotoxins and to prevent pyrogenic reactions in patients undergoing hemodialysis.
Royal Care Hospital Share Performance and Investment Overview
While analyzing Royal Care Hospital's share price, most potential investors are keen on knowing the recent trends and forecast. Currently, the Royal Care Hospital share price varies based on market situations, showing steady growth in alignment with the hospital’s performance.
In regard to Royal Care Hospital's share price target 2025, market experts predict enormous potential for growth based on the hospital’s performance growth, enhanced profitability, and healthcare innovations. Investors and experts closely monitor Royal Care Hospital's share name in the NSE, anticipating future returns as the hospital expands and improves its operations.
Services
-
Cardiology
-
Oncology
-
Neurology
-
Neurosurgery
-
Orthopedics
-
Gastroenterology
-
Nephrology
-
Pulmonology
-
& other specialty
Vision Statement
The company’s Vision is to create a world-class “Integrated Healthcare Delivery System”, incorporating best practices, the finest medical skills, the latest in technology and most recent advancement in therapeutics combined with compassionate patient care.
Our Mission
The company’s Mission is to reach out to the society as the most sought after healthcare provider for treating every ailing person, with comprehensive care, personal attention and empathy in a clean, safe and friendly environment at an affordable cost.”
Board of Directors
-
Dr. K. Madeswaran, Chairman Cum Managing Director
-
Dr. K. Chockalingam, Director
-
Sri. K.P. Alagesan, Director
-
Sri. K.M. Subramanian, Director
-
Mrs. M. Shanmugapriya, Director
-
Dr. S. Kalyanakumari, Director
-
Dr. P. Selvaraj, Director
-
Dr. S. Paulvannan, Director
-
Sri. K.K. Chandrasekar, Director
-
Sri. M.P. Prabhu, Director
-
Dr. N. Sudhakar, Director
-
Dr. M. Sudhakaran, Director
-
Dr. V.R. Pattabhiraman, Director
-
Dr. P. Chokkalingam, Director
-
Dr. S.P. Thiruppathy, Independent Director
-
Sri. K. Muthusamy, Independent Director
-
Sri. T. Balachander, Director Finance Cum CFO
-
CS. K. Rangasamy, Company Secretary
Listing Status
The company has not filed its DRHP yet.
Dividend Details
The Directors are not recommending any dividend for the financial year ending 31st March 2024.
IPO Details
The Company doesn't provide any information regarding the IPO plans.
Associate
-
M/s. VVSR Green Energy Private Ltd
Subsidiaries
The Hospital does not have any subsidiary companies.
Registered Address
The Registered office of the company is in Coimbatore, Tamil Nadu, India.
Fundamentals
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | - | 301.15 | 305.49 | 332.73 |
| Other Income | - | 4.22 | 5.16 | 5.19 |
| COGS | - | 71.23 | 68.57 | 72.76 |
| Gross Profit | - | 234.15 | 242.08 | 265.17 |
| Total Expense | - | 161.93 | 175.29 | 194.17 |
| EBIDTA | - | 72.22 | 66.79 | 71.00 |
| D&A | - | 23.72 | 24.39 | 24.53 |
| EBIT | - | 48.50 | 42.40 | 46.47 |
| Interest Expense | - | 27.17 | 26.84 | 22.15 |
| PBT | - | 21.32 | 15.56 | 24.32 |
| TAX | - | 0.09 | -0.11 | -0.17 |
| PAT | - | 21.23 | 15.68 | 24.48 |
| Diluted EPS | - | 1.29 | 0.95 | 1.43 |
| Basic EPS | - | 1.29 | 0.95 | 1.43 |
| Total income | 0.00 | 305.37 | 310.65 | 337.92 |
ASSETS
| CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash and Cash Equivalents | - | 8.31 | 5.04 | 27.25 |
| Trade Payables | - | 9.12 | 16.86 | 23.44 |
| Inventory | - | 6.51 | 9.01 | 13.31 |
| Other Current Assets | - | 14.40 | 14.25 | 9.51 |
| Total Current Assets | 0.00 | 38.34 | 45.16 | 73.51 |
| NON CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Plant Property and Equipment | - | 341.25 | 343.69 | 411.15 |
| Long Term Investment | - | 1.17 | 1.16 | 1.16 |
| Other Non Current Assets | - | 24.87 | 30.64 | 59.45 |
| TOTOAL NON CURRENT ASSSETS | 0.00 | 367.29 | 375.49 | 471.76 |
| Total Assets | 0.00 | 405.63 | 420.65 | 545.27 |
|---|
| CURRENT LIABILITES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| TRADW Payable | - | 6.16 | 12.47 | 29.99 |
| Other Current Liab | - | 62.92 | 60.43 | 67.48 |
| Total Current Liab | 0.00 | 69.08 | 72.90 | 97.47 |
| NON CURRENTLIABILITIES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Long Term Debt | - | 212.50 | 203.46 | 244.58 |
| Deffered Tax Liab | - | - | - | - |
| Other Non Current Liab | - | 6.01 | 10.60 | 8.50 |
LIABILITIES
| EQUITY | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | - | 164.38 | 164.38 | 171.02 |
| Reserves And Surplus | - | - | - | - |
| Other Equity | - | -46.34 | -30.67 | 23.70 |
| Retained Earnings | - | - | - | - |
| share Equity | 0.00 | 118.04 | 133.71 | 194.72 |
| Total Liabilities | 0.00 | 336.55 | 347.77 | 447.80 |
|---|
| CASH FLOW STAT | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash Flow from operating | - | 83.40 | 58.96 | 87.18 |
| Cash Flow from financing | - | -35.18 | -36.33 | 25.29 |
| Cash Flow from investing | - | -43.22 | -25.90 | -90.27 |
| Net cash flow | 0.00 | 5.00 | -3.27 | 22.20 |
Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
- The lockin period is of 6 months for pre-ipo investors i.e. they cannot sell their shares for 6 months after they get listed. However, they can definitely sell the shares in pre-ipo market before they get listed.
- With BharatInvest, you can now invest in unlisted/pre-ipo shares with as low as 25-50k depending upon the share.
- 1. You can download the NSDL or CDSL application and login into the account and check whether the shares have been credited or not.
- 2. Credit of Unlisted Shares/Pre-IPO shares can be checked in brokers application as well but it takes T+2 days to show the shares.
- The value of share in unlisted space is determined in the same way as it is done in listed market. Demand and supply decide the price of any share. If the demand more than the supply, then the prices of the share increases and vice versa.
- When a new shares is introduces in the unlisted space, the value of the company is decided upon the last funding raised by company. If the company hasn’t raised any funding in the past, then the valuation is decided upon the fundamentals of the company.
- A Public Unlisted Shares Is Not Listed on Stock Exchange, Where as a Listed Public Company Is Listed On Stock Exchange Such As BSE Or NSE For Trading Of Shares.
- If you sell your shares within 2 years, then you will have to pay Short-term Capital gain on unlisted shares. Short-Term Capital Gain is added in your Income. So, as per individual tax slab you need to pay capital gain tax.
- If you sell your shares after 2 years, then you will have to pay Long-term Capital gain on unlisted shares LTCG is 12.5% without indexation benefits.
- After listing of shares, the unlisted shares which you have bought through unlisted market, will be taxed at listed rates, if sold through exchange. So, taxes of listed market will be applicable. And, to calculate holding time, for determining LTCG or STCG, the purchase date of unlisted shares will be applicable.
- Absoluetly NOT! Grey market is all about speculation relation to open price, subscription rate etc. And does not include physical delivery of shares. Whereas in pre ipo market you get to invest in shares much before the ipo too and it involves physical delivery of shares. It is compeletly legal and does not include any such speculation.
- Existing stakeholders, promoters or employees who have equity shares of an unlisted company and early investors who wish to get value of their investment.
- Yes, investing in unlisted shares is undoubtedly legal in India. The trading takes place in the over-the-counter market.
Related News
No related news is available for Royal care Super Speciality Hospitals.